Summary:
The clinical trial of Indian Covid-19 vaccine candidate Covaxin began in Uttar Pradesh’s Kanpur and Gorakhpur hospitals on Friday.
In Kanpur, the first set of 22 volunteers were given the vaccine under strict medical supervision at the private Prakhar Hospital.
The medical facility in Kanpur and Gorakhpur’s Rana Hospital and Trauma Centre are among the 12 institutes across the country where the human trial of the vaccine, developed by Bharat Biotech, are being conducted.
.
Kanpur: The clinical trial of Indian Covid-19 vaccine candidate Covaxin began in Uttar Pradesh’s Kanpur and Gorakhpur hospitals on Friday.
In Kanpur, the first set of 22 volunteers were given the vaccine under strict medical supervision at the private Prakhar Hospital.
The medical facility in Kanpur and Gorakhpur’s Rana Hospital and Trauma Centre are among the 12 institutes across the country where the human trial of the vaccine, developed by Bharat Biotech, are being conducted.
A 26-year-old information technology (IT) professional from central Kanpur became the first person in Uttar Pradesh to get the vaccine dose.
The man expressed happiness at being a “part of an exercise being carried out to help mankind.” “I wanted to be a part of this.
I told my family members about my decision.
They were worried about the adverse side-effects (if any).